Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus.
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D000914:Antibodies, Viral / Q000032:analysis; D003428:Cross Infection / Q000517:prevention & control*; D017977:Deltaretrovirus / Q000276:immunology; D004203:Disinfection / Q000592:standards; D004797:Enzyme-Linked Immunosorbent Assay; D005189:False Positive Reactions; D015483:HIV Antibodies; D006280:Health Workforce; D006801:Humans; D009784:Occupational Diseases / Q000517:prevention & control; D010530:Peritoneal Dialysis / Q000592:standards*; D006435:Renal Dialysis / Q000592:standards*; D012192:Retroviridae Infections / Q000517:prevention & control*; D013242:Sterilization / Q000592:standards
D000914:Antibodies, Viral; D015483:HIV Antibodies